BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 32949144)

  • 1. Sialendoscopy increases saliva secretion and reduces xerostomia up to 60 weeks in Sjögren's syndrome patients: a randomized controlled study.
    Karagozoglu KH; Vissink A; Forouzanfar T; de Visscher JGAM; Maarse F; Brand HS; van de Ven PM; Jager DHJ
    Rheumatology (Oxford); 2021 Mar; 60(3):1353-1363. PubMed ID: 32949144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sialendoscopy enhances salivary gland function in Sjögren's syndrome: a 6-month follow-up, randomised and controlled, single blind study.
    Karagozoglu KH; Vissink A; Forouzanfar T; Brand HS; Maarse F; Jager DHJ
    Ann Rheum Dis; 2018 Jul; 77(7):1025-1031. PubMed ID: 29475854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized controlled trial to verify the irrigation of salivary glands in relieving xerostomia in patients with Sjögren's syndrome.
    Du H; Fu Z; Zhong Y; Yuan Y; Zhao J; Ding X; Li S; Gao S; Zhu Y; Song H; Wu H
    Front Immunol; 2022; 13():1039599. PubMed ID: 36439107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sialendoscopy of Salivary Glands Affected by Sjögren Syndrome: A Randomized Controlled Pilot Study.
    Jager DJ; Karagozoglu KH; Maarse F; Brand HS; Forouzanfar T
    J Oral Maxillofac Surg; 2016 Jun; 74(6):1167-74. PubMed ID: 26850868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined interventional sialendoscopy and intraductal steroid therapy for recurrent sialadenitis in Sjögren's syndrome: Results of a pilot monocentric trial.
    Capaccio P; Canzi P; Torretta S; Rossi V; Benazzo M; Bossi A; Vitali C; Cavagna L; Pignataro L
    Clin Otolaryngol; 2018 Feb; 43(1):96-102. PubMed ID: 28585263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraoperative visualisation and treatment of salivary glands in Sjögren's syndrome by contrast-enhanced ultrasound sialendoscopy (CEUSS): protocol for a phase I single-centre, single-arm, exploratory study.
    Karagozoglu KH; Helder M; Bot J; Kamp O; Forouzanfar T; Brand HS; Cha S; Weisman G; Bartelink I; Vissink A; Jager DHJ
    BMJ Open; 2020 Sep; 10(9):e033542. PubMed ID: 32998913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraoperative Visualization and Treatment of Salivary Gland Dysfunction in Sjögren's Syndrome Patients Using Contrast-Enhanced Ultrasound Sialendoscopy (CEUSS).
    Karagozoglu KH; Mahraoui A; Bot JCJ; Cha S; Ho JTF; Helder MN; Brand HS; Bartelink IH; Vissink A; Weisman GA; Jager DHJ
    J Clin Med; 2023 Jun; 12(12):. PubMed ID: 37373845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salivary gland ultrasonography as a primary imaging tool for predicting efficacy of xerostomia treatment in patients with Sjögren's syndrome.
    Takagi Y; Sumi M; Nakamura H; Sato S; Kawakami A; Nakamura T
    Rheumatology (Oxford); 2016 Feb; 55(2):237-45. PubMed ID: 26338664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corticosteroid irrigation of parotid gland for treatment of xerostomia in patients with Sjögren's syndrome.
    Izumi M; Eguchi K; Nakamura H; Takagi Y; Kawabe Y; Nakamura T
    Ann Rheum Dis; 1998 Aug; 57(8):464-9. PubMed ID: 9797551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive value of ultrasound scoring in relation to clinical and histological parameters in xerostomia patients.
    Jazzar A; Manoharan A; Brown JE; Shirlaw PJ; Carpenter GH; Challacombe SJ; Proctor GB
    Oral Dis; 2019 Jan; 25(1):150-157. PubMed ID: 30120806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-level laser therapy for xerostomia in primary Sjögren's syndrome: a randomized trial.
    Fidelix T; Czapkowski A; Azjen S; Andriolo A; Neto PH; Trevisani V
    Clin Rheumatol; 2018 Mar; 37(3):729-736. PubMed ID: 29119483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unstimulated whole salivary flow in Sjögren's Syndrome: systematic literature review and meta-analysis.
    Martínez-Ceballos MA; Aguilera N; Garzón-González KC; Cajamarca-Baron J; Alzate-Granados JP; Rojas-Villarraga A
    Adv Rheumatol; 2021 Feb; 61(1):8. PubMed ID: 33536075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance and Implications of Patient-reported Xerostomia in Sjögren's Syndrome: Findings From the National Institutes of Health Cohort.
    Billings M; Dye BA; Iafolla T; Baer AN; Grisius M; Alevizos I
    EBioMedicine; 2016 Oct; 12():270-279. PubMed ID: 27639822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initial clinical experience performing sialendoscopy for salivary gland protection in patients undergoing
    Rathke H; Kratochwil C; Hohenberger R; Giesel FL; Bruchertseifer F; Flechsig P; Morgenstern A; Hein M; Plinkert P; Haberkorn U; Bulut OC
    Eur J Nucl Med Mol Imaging; 2019 Jan; 46(1):139-147. PubMed ID: 30151743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient selection criteria for electrostimulation of salivary production in the treatment of xerostomia secondary to Sjogren's syndrome.
    Erlichman M
    Health Technol Assess Rep; 1990; (8):1-7. PubMed ID: 1369638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated therapy of intraductal irrigations and sialoendoscopies of salivary glands to improve mouth dryness.
    Aframian DJ; Bar O; Wilensky A; Nadler C; Almoznino G
    Oral Dis; 2024 Apr; 30(3):1198-1208. PubMed ID: 36630587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term effectiveness of a novel intra-oral electro-stimulator for the treatment of dry mouth in patients with Sjogren's syndrome: A randomised sham-controlled feasibility study (LEONIDAS-1).
    Fedele S; Al-Hamad A; Mercadante V; Porter S; Isenberg D; Poveda-Gallego A; Brown ST
    J Oral Pathol Med; 2023 Aug; 52(7):619-627. PubMed ID: 37220073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal evaluation of major salivary gland functioning in Sjögren's disease patients in a prospective standard-of-care cohort.
    Sluijpers NRF; Delli K; De Wolff L; Stel AJ; Spijkervet FKL; Kroese FGM; Bootsma H; Arends S; Vissink A
    Clin Exp Rheumatol; 2023 Dec; 41(12):2474-2483. PubMed ID: 38149509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minor salivary glands function is decreased in hyposalivation-related diseases.
    Wang Z; Li W; Hong X; Su JZ; Hua H; Peng X; Lv L; Yu GY
    Arch Oral Biol; 2016 Sep; 69():63-70. PubMed ID: 27243418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical evaluation of a commercially available oral moisturizer in relieving signs and symptoms of xerostomia in postirradiation head and neck cancer patients and patients with Sjögren's syndrome.
    Rhodus NL; Bereuter J
    J Otolaryngol; 2000 Feb; 29(1):28-34. PubMed ID: 10709169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.